XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income (loss) $ (25,854) $ 44,839
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 24,511 18,550
Change in fair value of contingent consideration 24,758 (5,632)
Share-based compensation expense 13,281 7,564
(Gain) loss on interest rate caps 1,407 (15,810)
Payment of contingent earnout consideration in excess of purchase price accrual (857) (11,117)
Amortization of deferred financing costs 1,239 1,286
Other loss 100 0
Changes in operating assets and liabilities:    
Premiums, commissions and fees receivable, net (48,351) (35,359)
Prepaid expenses and other current assets (4,859) (8,908)
Due to/from related parties (1) (89)
Right-of-use assets 1,149 (1,368)
Accounts payable, accrued expenses and other current liabilities (163) 627
Operating lease liabilities (468) 1,984
Other liabilities 77 0
Net cash used in operating activities (14,031) (3,433)
Cash flows from investing activities:    
Capital expenditures (3,499) (1,793)
Cash consideration paid for asset acquisitions (1,500) (700)
Investment in business ventures (100) (639)
Net cash used in investing activities (5,099) (3,132)
Cash flows from financing activities:    
Payment of contingent earnout consideration up to amount of purchase price accrual (4,680) (13,993)
Proceeds from revolving line of credit 50,000 40,000
Payments on revolving line of credit (70,000) 0
Payments on long-term debt (2,127) (2,127)
Payments of debt issuance costs 0 (1,188)
Proceeds from settlements of interest rate caps 2,275 0
Tax distributions to BRP LLC members (11) 0
Proceeds from repayment of stockholder notes receivable 21 44
Net cash provided by (used in) financing activities (24,522) 22,736
Net increase (decrease) in cash and cash equivalents and restricted cash (43,652) 16,171
Cash and cash equivalents and restricted cash at beginning of period 230,471 227,737
Cash and cash equivalents and restricted cash at end of period 186,819 243,908
Supplemental schedule of cash flow information:    
Cash paid during the period for interest 24,898 9,049
Disclosure of non-cash investing and financing activities:    
Right-of-use assets obtained in exchange for operating lease liabilities 3,071 5,336
Capital expenditures incurred but not yet paid 1,084 0
Right-of-use assets increased through lease modifications and reassessments 61 0
Increase in goodwill resulting from measurement period adjustments for prior year business combinations 0 3,658
Noncash debt issuance costs incurred $ 0 $ 92